Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03387527 · ClinicalTrials.gov registry record · NA
Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03387527 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT03387527, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a new counseling tool for patients deciding whether or not to undergo prostate cancer screening. This screening decision aid is a computer program that provides individual patients estimates of their risks of prostate cancer diagnosis, prostate cancer related death, or death from any cause. The researchers are evaluating whether or not patients find this screening decision aid helpful. As part of this study, participants will be asked for their response on questionnaires. If patients find the screening decision aid helpful, the researchers will make it available at other clinic locations.
Interventions
- BEHAVIORAL Prostate cancer decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2018-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03387527
The ClinicalTrials.gov registry entry for NCT03387527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prostate cancer decision aid is the first listed.
NCT03387527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03387527 about?
NCT03387527 is a clinical study titled "Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening". The purpose of this study is to evaluate a new counseling tool for patients deciding whether or not to undergo prostate cancer screening. This screening decision aid is a computer program that provides individual patients estimates of their risks of prostate cancer diagnosis, prostate cancer related...
What is the current status of trial NCT03387527?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-02-01. Estimated completion is 2018-11-03.
What interventions are being tested in trial NCT03387527?
The interventions under investigation include: Prostate cancer decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT03387527?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.